Issue 39, 2025

A two-decade overview of oxadiazole derivatives as promising anticancer agents

Abstract

One of the most difficult illnesses that people today must deal with is cancer. It is distinguished by aberrant cell division and growth, which results in the development of tumors and lumps. The heterocyclic nucleus has drawn a lot of interest in the field of chemotherapeutics; moreover, it is essential in medicinal chemistry. Oxadiazole is a nitrogen–oxygen heterocyclic core with five members that exhibits remarkable anticancer properties. Inhibiting different enzymes and growth factors is the mechanism linked to tumor defeat. This review has covered research conducted over the past 20 years as well as their potential applications in drug development as antineoplastic agents, given the significance of oxadiazole and its derivatives in this global panic problem. This review aims to highlight the anticancer properties of 1,3,4-oxadiazole and its derivatives, 1,2,4-oxadiazole.

Graphical abstract: A two-decade overview of oxadiazole derivatives as promising anticancer agents

Article information

Article type
Review Article
Submitted
26 May 2025
Accepted
01 Aug 2025
First published
10 Sep 2025
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2025,15, 32778-32795

A two-decade overview of oxadiazole derivatives as promising anticancer agents

M. Salem, K. El-Adl, A. El-morsy and H. S. Abulkhair, RSC Adv., 2025, 15, 32778 DOI: 10.1039/D5RA03702F

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements